Skip to main content

TV 5382 Pill - yellow capsule/oblong, 19mm

Pill with imprint TV 5382 is Yellow, Capsule/Oblong and has been identified as Abacavir Sulfate and Lamivudine 600 mg / 300 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Abacavir/lamivudine is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 5382

Abacavir sulfate and lamivudine 600 mg / 300 mg TV 5382

Abacavir Sulfate and Lamivudine

TV 5382
600 mg / 300 mg
19.00 mm
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-5382 (Discontinued)
Inactive Ingredients
FD&C Yellow No. 6, hypromellose 2910 (6 mPa.s), ferric oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.